HUP0104933A2 - MEK inhibitorok alkalmazása vírusellenes terápiában - Google Patents
MEK inhibitorok alkalmazása vírusellenes terápiábanInfo
- Publication number
- HUP0104933A2 HUP0104933A2 HU0104933A HUP0104933A HUP0104933A2 HU P0104933 A2 HUP0104933 A2 HU P0104933A2 HU 0104933 A HU0104933 A HU 0104933A HU P0104933 A HUP0104933 A HU P0104933A HU P0104933 A2 HUP0104933 A2 HU P0104933A2
- Authority
- HU
- Hungary
- Prior art keywords
- mek inhibitors
- antiviral method
- antiviral
- curative
- procedure
- Prior art date
Links
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 title abstract 2
- 230000000840 anti-viral effect Effects 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A jelen tal lm ny t rgya MEK inhibitorok, kül"n"sen (I) vagy (II) ltalnos képletű vegyületek hat sos mennyiségének alkalmaz savírusfertőzések gyógyító vagy megelőző kezelésére szolg ló elj r sban. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11502699P | 1999-01-07 | 1999-01-07 | |
PCT/US1999/030484 WO2000040237A1 (en) | 1999-01-07 | 1999-12-21 | Antiviral method using mek inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0104933A2 true HUP0104933A2 (hu) | 2002-04-29 |
HUP0104933A3 HUP0104933A3 (en) | 2003-12-29 |
Family
ID=22358895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0104933A HUP0104933A3 (en) | 1999-01-07 | 1999-12-21 | Antiviral method using mek inhibitors |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1140067A1 (hu) |
JP (1) | JP2002534381A (hu) |
AU (1) | AU2203800A (hu) |
CA (1) | CA2358438A1 (hu) |
HU (1) | HUP0104933A3 (hu) |
IL (1) | IL144103A0 (hu) |
WO (1) | WO2000040237A1 (hu) |
ZA (1) | ZA200104000B (hu) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU59801A (sh) | 1999-02-24 | 2005-07-19 | F. Hoffmann-La Roche Ag. | Fenil- i piridinil-derivati |
DE10017480A1 (de) * | 2000-04-07 | 2001-10-11 | Transmit Technologietransfer | Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren |
CN1219753C (zh) * | 2000-07-19 | 2005-09-21 | 沃尼尔·朗伯公司 | 4-碘苯氨基苯氧肟酸的氧合酯 |
EP1201765A3 (en) * | 2000-10-16 | 2003-08-27 | Axxima Pharmaceuticals Aktiengesellschaft | Cellular kinases involved in cytomegalovirus infection and their inhibition |
AU2002249261A1 (en) * | 2001-03-06 | 2002-09-19 | Axxima Pharmaceuticals Ag | Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock |
NZ518726A (en) | 2001-05-09 | 2004-06-25 | Warner Lambert Co | Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor |
DE10138912A1 (de) * | 2001-08-08 | 2003-02-27 | Medinnova Ges Med Innovationen | Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen |
HUE025767T2 (hu) | 2002-03-13 | 2016-05-30 | Array Biopharma Inc | N3-alkilezett benzimidazol származékok mint MEK inhibitorok |
US7235537B2 (en) | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
DOP2003000641A (es) | 2002-05-10 | 2003-11-15 | Pfizer | Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan |
US7144907B2 (en) | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7538120B2 (en) | 2003-09-03 | 2009-05-26 | Array Biopharma Inc. | Method of treating inflammatory diseases |
KR101013932B1 (ko) | 2003-10-21 | 2011-02-14 | 워너-램버트 캄파니 엘엘씨 | N-[(r)-2,3-디히드록시-프로폭시]-3,4-디플루오로-2-(2-플루오로-4-요오도페닐아미노)-벤자미드 다형체 형태 |
AU2004293019B2 (en) | 2003-11-19 | 2010-10-28 | Array Biopharma Inc. | Bicyclic inhibitors of MEK and methods of use thereof |
US7517994B2 (en) | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7732616B2 (en) | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
EP1684694A2 (en) | 2003-11-21 | 2006-08-02 | Array Biopharma, Inc. | Akt protein kinase inhibitors |
CN101006086B (zh) | 2004-06-11 | 2010-09-29 | 日本烟草产业株式会社 | 用于治疗癌症的5-氨基-2,4,7-三氧代-3,4,7,8-四氢-2H-吡啶并[2,3-d]嘧啶衍生物和相关化合物 |
US7378423B2 (en) | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
SE0401969D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Piperidine derivatives |
ES2405785T3 (es) | 2005-05-18 | 2013-06-03 | Array Biopharma Inc. | Inhibidores heterocíclicos de MEK y métodos de uso de los mismos |
NZ567140A (en) | 2005-10-07 | 2011-09-30 | Exelixis Inc | Azetidines as MEK inhibitors for the treatment of proliferative diseases |
EP2054418B1 (en) | 2006-07-06 | 2011-11-09 | Array Biopharma Inc. | Dihydrothieno pyrimidines as akt protein kinase inhibitors |
CA2656618C (en) | 2006-07-06 | 2014-08-26 | Array Biopharma Inc. | Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
ATE493418T1 (de) | 2006-07-06 | 2011-01-15 | Array Biopharma Inc | Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren |
US8063050B2 (en) | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
CN101605540A (zh) | 2006-12-14 | 2009-12-16 | 埃克塞利希斯股份有限公司 | 使用mek抑制剂的方法 |
JP5542282B2 (ja) | 2007-07-05 | 2014-07-09 | アレイ バイオファーマ、インコーポレイテッド | Aktプロテインキナーゼ阻害剤としてのピリミジルシクロペンタン |
US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
CN101801955B (zh) | 2007-07-05 | 2013-05-08 | 阵列生物制药公司 | 作为akt蛋白激酶抑制剂的嘧啶基环戊烷 |
AU2009204025B2 (en) | 2008-01-09 | 2014-02-20 | Array Biopharma Inc. | Hydroxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
AU2009204019B2 (en) | 2008-01-09 | 2014-02-20 | Array Biopharma Inc. | Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor |
ES2399384T3 (es) | 2008-11-10 | 2013-04-01 | Bayer Schering Pharma Ag | Sulfonamido fenoxibenzamidas sustituidas |
WO2011047788A1 (en) | 2009-10-21 | 2011-04-28 | Bayer Schering Pharma Aktiengesellschaft | Substituted benzosulphonamides |
EP2491014A1 (en) | 2009-10-21 | 2012-08-29 | Bayer Pharma Aktiengesellschaft | Substituted halophenoxybenzamide derivatives |
EP2491016A1 (en) | 2009-10-21 | 2012-08-29 | Bayer Pharma Aktiengesellschaft | Substituted benzosulphonamides |
WO2011155898A1 (en) * | 2010-06-11 | 2011-12-15 | Wadell Goeran | New antiviral compounds |
EP2632899A1 (en) | 2010-10-29 | 2013-09-04 | Bayer Intellectual Property GmbH | Substituted phenoxypyridines |
RU2631240C2 (ru) | 2011-04-01 | 2017-09-20 | Дженентек, Инк. | Комбинации соединений-ингибиторов акт и абиратерона, и способы применения |
MX2013011333A (es) | 2011-04-01 | 2014-04-16 | Genentech Inc | Combinaciones de compuestos inhibidores de akt y mek, y metodos de uso. |
US9566281B2 (en) * | 2012-10-08 | 2017-02-14 | Atriva Therapeutics Gmbh | MEK inhibitors in the treatment of virus diseases |
SI2909188T1 (en) | 2012-10-12 | 2018-07-31 | Exelixis, Inc. | A novel process for the manufacture of compounds for use in the treatment of cancer |
EP3043790B1 (en) | 2013-09-11 | 2021-05-26 | The Administrators of the Tulane Educational Fund | Novel anthranilic amides and the use thereof |
CA3078424A1 (en) * | 2017-10-17 | 2019-04-25 | Atriva Therapeutics Gmbh | 2-(2-chloro-4-iodophenylamino)-3,4-difluorobenzoic acid for the treatment fo viral and bacterial infections |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6420338B1 (en) * | 1997-06-13 | 2002-07-16 | New York University Medical Center | Inhibition of the Src kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
DE69836378T2 (de) * | 1997-07-01 | 2007-10-11 | Warner-Lambert Co. Llc | Benzoesäure- und Benzamid-Derivate von Anthranilsäure und ihre Anwendung als MEK-Inhibitoren |
PT993439E (pt) * | 1997-07-01 | 2004-12-31 | Warner Lambert Co | Derivados de acido 4-bromo ou 4-iodofenilaminobenzidroxamico e sua utilizacao como inibidores de mek |
-
1999
- 1999-12-21 JP JP2000591994A patent/JP2002534381A/ja active Pending
- 1999-12-21 HU HU0104933A patent/HUP0104933A3/hu unknown
- 1999-12-21 AU AU22038/00A patent/AU2203800A/en not_active Abandoned
- 1999-12-21 CA CA002358438A patent/CA2358438A1/en not_active Abandoned
- 1999-12-21 EP EP99966522A patent/EP1140067A1/en not_active Withdrawn
- 1999-12-21 IL IL14410399A patent/IL144103A0/xx unknown
- 1999-12-21 WO PCT/US1999/030484 patent/WO2000040237A1/en not_active Application Discontinuation
-
2001
- 2001-05-16 ZA ZA200104000A patent/ZA200104000B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL144103A0 (en) | 2002-05-23 |
CA2358438A1 (en) | 2000-07-13 |
JP2002534381A (ja) | 2002-10-15 |
ZA200104000B (en) | 2002-08-16 |
HUP0104933A3 (en) | 2003-12-29 |
WO2000040237A1 (en) | 2000-07-13 |
EP1140067A1 (en) | 2001-10-10 |
AU2203800A (en) | 2000-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0104933A2 (hu) | MEK inhibitorok alkalmazása vírusellenes terápiában | |
ES2160046A1 (es) | Derivados pentapeptidicos. | |
ATE550320T1 (de) | Antivirales mittel | |
NO20003233L (no) | 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler | |
NZ303861A (en) | Amino acid hydroxyethylamine sulphonamide derivatives as protease inhibitors | |
TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
ES2191292T3 (es) | Compuestos antivirales poliaromaticos. | |
MX9706913A (es) | Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos. | |
AU2003291885A1 (en) | Compounds and methods for the treatment or prevention of flavivirus infections | |
ATE229945T1 (de) | Zur behandlung von cmv infektionen geeignete 1,3, 4-thiadiazole | |
TR200002480T2 (tr) | İzaşemi tedavisi için guanidin türevleri | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
BR0305258A (pt) | Inibidores de polimerase de ns5b de hcv | |
ATE283856T1 (de) | Zyklische guanosine 3',5'-monophosphate phosphodiesterase inhibitoren | |
MX9706946A (es) | Inhibidores de la proteasa retroviral de la hidroxietilaminosulfonamida de aminoacidos heterociclicocarbonilicos y uso de los mismos. | |
BR9607450A (pt) | Inibidores de protease retroviral sulfonilalcanoilamino hidroxietilamino sulfonamida | |
NZ502988A (en) | 5-Acetamido-4-amino-2-propionyloxy-6-isopropoxy-1-cyclohexene useful for treating influenza | |
BR0215067A (pt) | Piridoquinoxalinas antivirais | |
YU44102A (sh) | Ciklična kvaternerna amonijum jedinjenja | |
EA200100711A1 (ru) | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция | |
NO972905L (no) | Tienoksasinon-derivater anvendelige som antivirusmidler | |
WO2002010124A3 (en) | Salt forms of an hiv protease inhibitor | |
EP0355409A3 (en) | Use of prolylendopeptidase inhibitors in the treatment of aids | |
HUP0004621A2 (hu) | Egy HIV proteáz inhibitor fokozott orális felszívódást és biológiai hozzáférhetőséget mutató szulfátsója | |
HUP9902191A2 (hu) | Az érképződést gátló anyag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |